Stock ACUT ACCUSTEM SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AccuStem Sciences, Inc.

Equities

ACUT

US00444A1016

Market Closed - OTC Markets
Other stock markets
 15:27:01 2024-05-22 EDT 		5-day change 1st Jan Change
0.35 USD +11.09% Intraday chart for AccuStem Sciences, Inc. +26.35% -44.06%
05-20 AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-22 AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
AQ
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership
CI
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
AQ
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023
CI
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AQ
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
CI
AccuStem Announce Strategic Clinical and Operational Partnership
AQ
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership
CI
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
AQ
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
AQ
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
AQ
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACUT Stock
  4. News AccuStem Sciences, Inc.